Loading organizations...
§ Private Profile · Philadelphia, PA, USA
Biopharmaceutical company developing gene therapies for cardiovascular dise
Renovacor has raised $11.0M across 1 funding round.
Renovacor has raised $11.0M in total across 1 funding round.
Renovacor has raised $11.0M across 1 funding round. Most recently, it raised $11.0M Series A in August 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 14, 2019 | $11M Series A | BioAdvance, Thomas Needham, Campbell Murray | Innogest, NEW Leaf Venture Partners | Announced |
Renovacor has raised $11.0M in total across 1 funding round.
Renovacor's investors include BioAdvance, Thomas Needham, Campbell Murray, Innogest, New Leaf Venture Partners.